Greg Lucier founded Corza Health in partnership with leading private equity firm GTCR to combine his 30+ years of life sciences leadership with GTCR’s unrivaled track record of creating unique, value-generating private equity opportunities.
Greg most recently served as CEO at NuVasive, a world leader in minimally invasive spine surgery technology. Prior to that, he was CEO at Life Technologies—formerly Invitrogen—which he grew into a global life sciences powerhouse that was acquired by Thermo Fisher Scientific for approximately $15 billion. He spent the first part of his career with the General Electric Company in a variety of executive roles.
Lucier remains the Chairman of Nuvasive, and serves on several public and private company boards, including Catalent, a leader in advanced pharmaceutical manufacturing services, Dentsply Sirona, a global provider of professional dental products and technologies, and Epic Sciences, a venture-backed company revolutionizing the use of cellular imaging to change cancer therapy.
Lucier holds a Bachelor’s in Industrial Engineering from Pennsylvania State University (graduating with distinction) and a Master’s in Business Administration from Harvard Business School.
In his free time, Greg enjoys riding motorcycles—both on and off-road—as well as skiing, which he is known to do anywhere and anytime he can.